Chronic Obstructive Pulmonary Disease (COPD) is a long-term, inflammatory lung condition that causes airflow obstruction and reduced lung function. In short, COPD makes it hard to breathe.

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung ...

Chronic emphysema is a type of chronic obstructive pulmonary disease (COPD) caused by damage to the air sacs in the lungs. Although there is no cure, you can manage the disease with lifestyle changes ...

Adults hospitalized for acute COPD exacerbation faced elevated odds for all-cause mortality and ICU admission if they had end-stage renal disease and were on dialysis, according to data presented at ...

Anyone who breathes can develop COPD. The world is at risk, and chronic respiratory diseases must be treated as both a global ...

Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study ...

Chronic obstructive pulmonary disease (COPD) is a group of diseases that affect the lungs. The disease makes it difficult to breath and progressively gets worse. About 15 million Americans have been ...

COPD is no longer solely a smoker's illness. Urban pollution, indoor cooking smoke, and even genetics contribute to rising ...

Long-term exposure to air pollution was linked to increases in emphysema between 2000 and 2018, according to a new study. Long-term exposure to air pollution was linked to increases in emphysema ...

Temple Health leads research showing how women and non-smokers face rising risks, and how new treatments are changing the ...

Please provide your email address to receive an email when new articles are posted on . The likelihood for cardiovascular disease increased with impaired vs. normal spirometry findings. Individuals ...

Growth is driven by rising COPD cases due to smoking and pollution, and enhanced therapeutic options like bronchodilators and biologics. Significant investments are improving diagnosis and treatment.